These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10461359)

  • 1. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
    Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
    Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of ECL-cell abnormalities.
    Hirschowitz BI
    Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis].
    Rappel S; Rindi G; Bordi C; Capella C; Solcia E; Altendorf-Hofmann A; Stolte M
    Verh Dtsch Ges Pathol; 1996; 80():199-207. PubMed ID: 9065002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of ECL cell tumors.
    Cadiot G; Cattan D; Mignon M
    Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
    Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
    Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
    Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
    Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A: is it a useful marker of neuroendocrine tumors?
    Campana D; Nori F; Piscitelli L; Morselli-Labate AM; Pezzilli R; Corinaldesi R; Tomassetti P
    J Clin Oncol; 2007 May; 25(15):1967-73. PubMed ID: 17513802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastric neuroendocrine tumor].
    Díaz-Sánchez CL; Molano Romero RA; Martínez González M; Márquez Rivera ML; Halabe-Cherem J
    Rev Gastroenterol Mex; 1998; 63(2):97-100. PubMed ID: 10068736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of ECL cell tumors in humans.
    Bordi C; D'Adda T; Azzoni C; Ferraro G
    Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
    Solcia E; Fiocca R; Villani L; Luinetti O; Capella C
    Am J Surg Pathol; 1995; 19 Suppl 1():S1-7. PubMed ID: 7762735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in human gastric carcinoma.
    Waldum HL; Aase S; Kvetnoi I; Brenna E; Sandvik AK; Syversen U; Johnsen G; Vatten L; Polak JM
    Cancer; 1998 Aug; 83(3):435-44. PubMed ID: 9690535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.